In field evaluations over three growing seasons and in both upland and lowland rice production systems, rice lines with Arcadia’s NUE trait showed substantial yield increases under different nitrogen application rates. The leading NUE rice line showed a 34 percent increase over controls.
“This study indicates that Arcadia’s NUE trait can support enhanced
yields for the world’s most important food crop,” said Raj Ketkar,
president and CEO of Arcadia. “While the CIAT study references NERICA
rice varieties, we believe our NUE trait can generate significant yield
gains, reduce the use of nitrogen fertilizer, and improve on-farm
economics for farmers growing rice varieties currently being
Rice is the world’s most valuable crop, grown on more than 405 million
acres globally with a harvest value of
Arcadia’s NUE trait was developed to help farmers increase yields and reduce their use of nitrogen fertilizer, a staple in the agricultural industry for increasing crop yield. Conventional crops only use about half of applied nitrogen fertilizer. Much of the remainder moves through the soil and enters ground and surface water systems, or volatilizes into the air as a greenhouse gas 300 times more potent than carbon dioxide.
Arcadia’s NUE trait enables plants to use nitrogen more efficiently, helping farmers improve yields while reducing costly fertilizer inputs and improving the environmental footprint of agriculture. The trait’s efficacy has been demonstrated in multiple crops, including rice, wheat, barley and canola.
Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995,
including statements relating to the company’s NUE trait and the
regulatory process for such trait. Forward-looking statements are
subject to risks and uncertainties that could cause actual results to
differ materially, and reported results should not be considered as an
indication of future performance. These risks and uncertainties include,
but are not limited to: the company’s and its partners’ and affiliates’
ability to identify and isolate desired traits; the company’s and its
partners’ ability to develop commercial products incorporating its
traits, including NUE, and complete the regulatory review process for
such products; the company’s compliance with laws and regulations that
impact the company’s business, and changes to such laws and regulations;
the company’s future capital requirements and ability to satisfy its
capital needs; and the other risks set forth in the company’s filings
Arcadia Biosciences, Inc.
View printer-friendly version